| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 55, 459-464, Copyright © 1982 by Endocrine Society
ARTICLES |
E Muls, V Blaton, M Rosseneu, E Lesaffre, G Lamberigts and P De Moor
The serum concentrations of total cholesterol (TC), triglycerides (RG), high density lipoprotein-cholesterol (HDLc), low density lipoprotein- cholesterol (LDLc), and the apolipoproteins (apo) A-I, A-II, and B were measured in 33 hyperthyroid patients before and after treatment. The results were compared with those of healthy controls. Apo A-I, A-II, and B were assayed by immunonephelometry. The serum levels of TC (mean +/- SD, 167 +/- 36 mg/dl, HDLc (40.8 +/- 12 mg/dl), and LDLc (108 +/- 35 mg/dl) were decreased in the untreated hyperthyroid patients compared to both the values after treatment (TC: 215 +/- 54 mg/dl; P less than 0.001; HDLc: 52 +/- 14 mg/dl; P less than 0.001; LDLc: 146 +/- 47 mg/dl; P less than 0.001) and the control values (TC: 206 + 39 mg/dl; P less than 0.001; HDLc: 47.4 +/- 10 mg/dl; P les than 0.01; LDLc: 145 +/- 38 mg/dl; P less than 0.001). TG levels were not statistically different before and after treatment. The apo A-I concentrations (116 +/- 24 mg/dl) were lower before than after treatment (131 +/- 28 mg/dl; P less than 0.01), but they were not statistically different from those in the control group (115 +/- 19 mg/dl). The apo A-II levels were identical in all groups (before treatment, 35 +/- 7 mg/dl; after treatment, 37 +/- 9 mg/dl; control group, 36 +/- 9 mg/dl). The apo B levels were lower in the untreated hyperthyroid patients (86 +/- 23 mg/dl) compared to those in controls (103 +/- 19 mg/dl; P less than 0.001) and patients after therapy (103 +/- 25 mg/dl; P less than 0.001). The increase in HDLc relative to the major HDL apo A-I and A-II during treatment for hyperthyroidism was associated with changes in body weight. The apo A-I to apo A-II and LDLc to apo B ratios, however, were significantly lower before compared to those after treatment, when the influence of increasing body weight during therapy was accounted for. This study emphasizes the important regulating role of thyroid hormones on lipid and apolipoprotein metabolism.
This article has been cited by other articles:
![]() |
M. J. M. Diekman, N. Anghelescu, E. Endert, O. Bakker, and W. M. Wiersinga Changes in Plasma Low-Density Lipoprotein (LDL)- and High-Density Lipoprotein Cholesterol in Hypo- and Hyperthyroid Patients Are Related to Changes in Free Thyroxine, Not to Polymorphisms in LDL Receptor or Cholesterol Ester Transfer Protein Genes J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1857 - 1862. [Abstract] [Full Text] |
||||
![]() |
B. Bülow, L. Hagmar, J. Eskilsson, and E. M. Erfurth Hypopituitary Females Have a High Incidence of Cardiovascular Morbidity and an Increased Prevalence of Cardiovascular Risk Factors J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 574 - 584. [Abstract] [Full Text] |
||||
![]() |
K. C. B. Tan, S. W. M. Shiu, and A. W. C. Kung. Effect of Thyroid Dysfunction on High-Density Lipoprotein Subfraction Metabolism: Roles of Hepatic Lipase and Cholesteryl Ester Transfer Protein J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2921 - 2924. [Abstract] [Full Text] |
||||
![]() |
K. C. B. Tan, S. W. M. Shiu, and A. W. C. Kung Plasma Cholesteryl Ester Transfer Protein Activity in Hyper- and Hypothyroidism J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 140 - 143. [Abstract] [Full Text] |
||||
![]() |
J. Blangero, S. Williams-Blangero, M. C. Mahaney, A. G. Comuzzie, J. E. Hixson, P. B. Samollow, R. M. Sharp, M. P. Stern, and J. W. MacCluer Effects of a Major Gene for Apolipoprotein A-I Concentration Are Thyroid Hormone Dependent in Mexican Americans Arterioscler. Thromb. Vasc. Biol., September 1, 1996; 16(9): 1177 - 1183. [Abstract] [Full Text] |
||||
![]() |
A. G. Comuzzie, J. Blangero, M. C. Mahaney, R. M. Sharp, J. L. VandeBerg, M. P. Stern, and J. W. MacCluer Triiodothyronine Exerts a Major Pleiotropic Effect on Reverse Cholesterol Transport Phenotypes Arterioscler. Thromb. Vasc. Biol., February 1, 1996; 16(2): 289 - 293. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |